Jaime Ardila Net Worth

The estimated Net Worth of Jaime Ardila is at least $6.82 Milione dollars as of 27 December 2023. Mr. Ardila owns over 3,000 units of Accenture plc stock worth over $3,990,732 and over the last 14 years he sold ACN stock worth over $2,489,177. In addition, he makes $344,865 as Independent Director at Accenture plc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Ardila ACN stock SEC Form 4 insiders trading

Jaime has made over 39 trades of the Accenture plc stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 3,000 units of ACN stock worth $1,059,540 on 27 December 2023.

The largest trade he's ever made was exercising 18,683 units of Accenture plc stock on 11 February 2016 worth over $6,544,842. On average, Jaime trades about 3,022 units every 44 days since 2010. As of 27 December 2023 he still owns at least 11,392 units of Accenture plc stock.

You can see the complete history of Mr. Ardila stock trades at the bottom of the page.

Jaime Ardila biography

Jaime Ardila serves as Independent Director of the Company since August 20, 2013. He was formerly the executive vice president of automobile manufacturer General Motors Company (“GM”), president of GM’s South America region and was a member of GM’s executive committee, from 2010 until his retirement in March 2016. He previously served as president and managing director of GM’s operations in Brazil, Argentina, Uruguay and Paraguay from November 2007 to June 2010. Prior to serving in that role, he served as vice president and chief financial officer of GM’s Latin America, Africa and Middle East region from March 2003 to October 2007, as president and managing director of GM Argentina from March 2001 to February 2003, and as president of GM Colombia from March 1999 to March 2001. Mr. Ardila joined GM in 1984 and held a variety of financial and senior positions with the company, primarily in Latin America, as well as in Europe and the United States. From 1996 to 1998, Mr. Ardila served as the managing director, Colombian Operations, of N M Rothschild & Sons Ltd and then rejoined GM in 1998 as president of GM Ecuador. Mr. Ardila is chairman of the board of Goldman Sachs BDC, Inc. and a director of Nexa Resources S.A. He previously served on the board of Ecopetrol S.A. from 2016 to 2019.

What is the salary of Jaime Ardila?

As the Independent Director of Accenture plc, the total compensation of Jaime Ardila at Accenture plc is $344,865. There are 10 executives at Accenture plc getting paid more, with David Rowland having the highest compensation of $15,031,900.

How old is Jaime Ardila?

Jaime Ardila is 64, he's been the Independent Director of Accenture plc since 2013. There are 2 older and 29 younger executives at Accenture plc. The oldest executive at Accenture plc is Herbert Hainer, 65, who is the Independent Director.

What's Jaime Ardila's mailing address?

Jaime's mailing address filed with the SEC is C/O ACCENTURE, 500 W. MADISON STREET, CHICAGO, IL, 60661.

Insiders trading at Accenture plc

Over the last 14 years, insiders at Accenture plc have traded over $571,571,901 worth of Accenture plc stock and bought 20,000 units worth $1,439,800 . The most active insiders traders include Beth E Mooney, Venkata S M Renduchintala e Pierre Nanterme. On average, Accenture plc executives and independent directors trade stock every 8 days with the average trade being worth of $2,487,902. The most recent stock trade was executed by Ellyn Shook on 23 July 2024, trading 5,000 units of ACN stock currently worth $1,649,100.

What does Accenture plc do?

Accenture plc is an Irish-American professional services company based in Dublin, specializing in information technology services and consulting. A Fortune Global 500 company, it reported revenues of $61.6 billion in 2022.

Complete history of Mr. Ardila stock trades at Accenture plc, General Motors e Goldman Sachs BDC Inc

Accenture plc executives and stock owners

Accenture plc executives and other stock owners filed with the SEC include:

• David Rowland,
  Executive Chairman of the Board
• Julie T. Spellman Sweet,
  CEO & Chairman
• Julie Sweet,
  Chief Executive Officer, Director
• Gianfranco Casati,
  Group Chief Executive - Growth Markets
• Gianfranco Casati,
  Chief Exec. Officer of Growth Markets
• KC McClure,
  Chief Financial Officer
• Jean-Marc Ollagnier,
  Chief Exec. Officer of Europe
• Kathleen R. McClure,
  Chief Financial Officer
• David P. Rowland,
  Exec. Chairman & Advisor to CEO
• Paula Price,
  Independent Director
• Jaime Ardila,
  Independent Director
• Nancy McKinstry,
  Independent Director
• Tracey Travis,
  Independent Director
• Gilles Christian Pelisson,
  Lead Independent Director
• Arun Sarin,
  Independent Director
• Herbert Hainer,
  Independent Director
• Venkata Renduchintala,
  Independent Director
• Frank Tang,
  Independent Director
• Joel Unruch,
  Chief Compliance Officer, General Counsel, Secretary
• James Etheredge,
  Chief Executive, North America
• Domingo Miron,
  Group Chief Executive - Financial Services
• Simon Eaves,
  Group Chief Executive - Products Operating Group
• John Walsh,
  Group Chief Executive Officer - Communications, Media and Technology
• Richard Clark,
  Chief Accounting Officer, Corporate Controller
• Ellyn Shook,
  Chief Human Resource Officer, Chief Leadership Officer
• Johan Deblaere,
  Chief Operating Officer, Chief Executive - Europe
• Jean-Marc Ollagnier,
  Group Chief Executive - Resources Operating Group
• Daniel London,
  Group Chief Executive - Health & Public Service Operating Group
• Jill Kramer,
  Chief Marketing & Communications Officer
• Joel Unruch,
  Gen. Counsel & Corp. Sec.
• Joel F. Unruch,
  Gen. Counsel & Corp. Sec.
• Angie Park,
  Managing Director & Head of Investor Relations
• Paul R. Daugherty,
  Group Chief Exec. of Technology & CTO
• Richard P. Clark,
  Chief Accounting Officer & Chief Transformation Officer – Bus. Enablement
• Johan G. Deblaere,
  Chief Operating Officer
• Omar Abbosh,
  Grp Chief Exec-Com, Med & Tech
• Charles H Giancarlo,
  Director
• Dina Dublon,
  Director
• William L Kimsey,
  Director
• Robert E Sell,
  Grp Chief Exec-Com, Med & Tech
• Marjorie Magner,
  Director
• Chad T Jerdee,
  General Counsel and CCO
• Wulf Von Schimmelmann,
  Director
• Blythe J Mcgarvie,
  Director
• Beth E Mooney,
  Director
• Leonardo Framil,
  CEO-Growth Markets
• Melissa A Burgum,
  Chief Accounting Officer
• Kathleen R Mc Clure,
  Chief Financial Officer
• Stephen J Rohleder,
  Group Chief Exec-Health & PS
• Mark Moodystuart,
  Director
• Nobuyuki Idei,
  Director
• Michael J Salvino,
  Group Chief Exec-Bus Proc Out
• Shawn Collinson,
  Sr Managing Dir-Growth & Strat
• Martin I Cole,
  Grp Chief Exec-Comm & HighTech
• 'T Noordende Alexander M Van,
  Group Chief Exec-Products
• Pierre Nanterme,
  Chief Executive Officer
• Jill Smart,
  Chief Human Resources Officer
• Richard Lumb,
  Group Chief Executive-Fin Serv
• Robert I Lipp,
  Director
• William D Green,
  Chairman
• Anthony G Coughlan,
  Principal Accounting Officer
• Pamela J. Craig,
  Chief Financial Officer
• Dennis F Hightower,
  Director
• Jeffrey D Osborne,
  Chief Performance Officer
• Kevin M Campbell,
  Group Chief Exec-Technology
• Robert N Frerichs,
  Group Chief Exec-North America
• Martin Brudermueller,
  Director
• Alan C. Jope,
  Director
• Angela Beatty,
  Chief Leadership & HR Officer
• Manish Sharma,
  CEO-Americas